used magnetic transferrin nanoparticles (MTNs) to isolate neurological disease‐derived biomarkers.[236] MTNs are functionalized nanoparticles that bind to transferrin receptors on exosome surfaces and allow for exosome isolation from complex samples. This evidence concerns the gene TF and nervous system disorder.